The pEGFP-Tid1 wildtype and mutants constructs (Fig. 1A) were transfected into the human breast cancer MCF-7 cell line and immunoblotting was performed using anti-GFP antibody to checked the molecular weight of the generated fusion proteins and their proper processing (Fig. 1B). This evidence concerns the gene DNAJA3 and breast carcinoma.